SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Oct-24 4:22 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 11-Oct-24 | Market Sale (Planned) | 10,757 | $13.57 | $146,004.00 | (4%) 247.61K to 236.85K | (5%) |
12-Jul-24 4:37 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 11-Jul-24 | Market Sale (Planned) | 10,757 | $13.14 | $141,394.00 | (4%) 258.37K to 247.61K | (8%) |
13-Jun-24 5:33 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 11-Jun-24 | Market Sale (Planned) | 96,815 | $12.94 | $1,252,720.00 | (27%) 352.28K to 255.46K | (10%) |
16-Feb-23 4:54 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Private Purchase | 6,250 | $16.00 | $100,000.00 | 2% 344.56K to 350.81K | |
13-Feb-18 5:02 PM View: | Viridian Therapeutics, Inc.... (VRDN) | 13-Feb-18 | Market Purchase | 9,090 | $5.50 | $49,995.00 | 627% 1.45K to 10.54K | (69%) |
23-Jun-17 7:07 PM View: | Viridian Therapeutics, Inc.... (VRDN) | 22-Jun-17 | Market Purchase | 200 | $7.55 | $1,510.00 | 100% 0 to 0.2K | (77%) |